Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-09

Clinical Trial Update: TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 trial evaluated whether combining physical therapy with atomoxetine and methylphenidate could improve gait and balance in Parkinson's disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine (Atomoxetine)
  • Methylphenidate (Methylphenidate)

Snippet

Sponsor: Hubert Fernandez | Conditions: Parkinson's Disease, Idiopathic | EARLY_Phase 1 | Status: COMPLETED